{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:16:35Z","timestamp":1648779395227},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.transproceed.2011.01.042","type":"journal-article","created":{"date-parts":[[2011,4,19]],"date-time":"2011-04-19T05:34:13Z","timestamp":1303191253000},"page":"547-550","source":"Crossref","is-referenced-by-count":2,"title":["Universal Prophylaxis With Gancyclovir Preparation Is Not Necessary in Our Kidney Allograft Recipients"],"prefix":"10.1016","volume":"43","author":[{"given":"H.","family":"Tayebi-Khosroshahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Makhdami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.K.","family":"Heris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Habibzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Zadimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Badrogli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2011.01.042_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1399-3062.2001.00001.x","article-title":"Cytomegalovirus in solid organ transplantation","volume":"3","author":"Rubin","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2011.01.042_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0966-3274(99)80023-9","article-title":"Role of cytomegalovirus infection in allograft rejection: a review of possible mechanisms","volume":"7","author":"Borchers","year":"1999","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.transproceed.2011.01.042_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1128\/CMR.13.1.83-121.2000","article-title":"New strategies for prevention and therapy of cytomegalovirus infection and disease in solid organ transplant recipients","author":"Sia","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.transproceed.2011.01.042_bib4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00007890-199201000-00013","article-title":"Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3","volume":"53","author":"Hibberd","year":"1992","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.01.042_bib5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1399-0012.2006.00618.x","article-title":"Cytomegalovirus in transplantation\u2014challenging the status quo","volume":"21","author":"Fishman","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2011.01.042_bib6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/rmv.513","article-title":"Antiviral drugs for cytomegalovirus in transplant recipients: advantages of preemptive therapy","volume":"16","author":"Singh","year":"2006","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.transproceed.2011.01.042_bib7","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1681\/ASN.V124848","article-title":"Cytomegalovirus in renal transplantation","volume":"12","author":"Brennan","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2011.01.042_bib8","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0272-6386(97)90205-5","article-title":"The effects of cytomegalovirus serology on graft and recipient survival in cadaveric renal transplantation: implications for organ allocation","volume":"29","author":"Schnitzler","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2011.01.042_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00003495-199855010-00005","article-title":"Management of cytomegalovirus infection after solid organ or stem-cell transplantation","volume":"55","author":"Hebart","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.transproceed.2011.01.042_bib10","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1600-6143.2004.00451.x","article-title":"Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2011.01.042_bib11","article-title":"Cytomegalovirus prophylaxis with antiviral agents for solid organ transplantation","author":"Couchoud","year":"2000","journal-title":"Cochrane Database"},{"key":"10.1016\/j.transproceed.2011.01.042_bib12","doi-asserted-by":"crossref","first-page":"984","DOI":"10.7326\/0003-4819-119-10-199311150-00004","article-title":"Cytomegalovirus immune globulin prophylaxis in liver transplantation","volume":"119","author":"Snydman","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transproceed.2011.01.042_bib13","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients","volume":"4","author":"Paya","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2011.01.042_bib14","first-page":"858","article-title":"Effect of prophylactic ganciclovir on cytomegalovirus infection in renal transplant recipients","volume":"8","author":"Rondeau","year":"1993","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2011.01.042_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1399-0012.2006.00618.x","article-title":"Cytomegalovirus in transplantation\u2014challenging the status quo","volume":"21","author":"Fishman","year":"2007","journal-title":"Clin Transplant"},{"issue":"Issue 2","key":"10.1016\/j.transproceed.2011.01.042_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003774.pub3","article-title":"Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients","author":"Hodson","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.transproceed.2011.01.042_bib17","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1111\/j.1600-6143.2006.01413.x","article-title":"Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients","volume":"6","author":"Khoury","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2011.01.042_bib18","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1600-6143.2007.02133.x","article-title":"Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial","volume":"8","author":"Kliem","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2011.01.042_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1399-3062.2004.00066.x","article-title":"Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease","volume":"6","author":"Taber","year":"2004","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2011.01.042_bib20","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","article-title":"The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients","volume":"10","author":"Humar","year":"2010","journal-title":"Am J Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134511000431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134511000431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T21:41:57Z","timestamp":1637530917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134511000431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0041134511000431"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2011.01.042","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}